Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery
- Sponsor
- Antalya City Hospital
- Study ID
- NCT07536867
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Breast Cancer
- Lymph Node Dissection
- Mastectomy
- Postoperative Pain
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Serratus posterior superior intercostal plane block — PROCEDUREUltrasound-guided serratus posterior superior intercostal plane block (SPSIPB) performed at the upper thoracic level for postoperative analgesia following breast cancer surgery.
- Rhomboid intercostal plane block — PROCEDUREUltrasound-guided rhomboid intercostal block (RIB) performed for postoperative analgesia following breast cancer surgery.
Study Details
This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Serratus Posterior Superior Intercostal Plane (SPSIP) and Rhomboid Intercostal Block in patients undergoing Breast Cancer Surgery With Axillary Lymph Node Dissection. The primary outcome is Visual Analog Scale (VAS) during the first 24 hours after surgery. Secondary outcomes include total opioid consumption, requirement for rescue analgesia, block performance time, block-related and systemic side effects (hematoma, pneumothorax, local anesthetic toxicity, vascular puncture, infection), Patient satisfaction assessed using a Likert scale, quality of recovery assessed using the QoR-15 questionnaire.
Key Dates
- First listed
- Apr 17, 2026
- Start date
- Aug 30, 2026
- Status verified
- Apr 2026
- Primary completion
- Aug 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: SERRATUS POSTERİOR SUPERİOR İNTERCOSTAL PLANE BLOCK (SPSIPB)PATİENTS İN THİS GROUP WİLL RECEİVE AN ULTRASOUND-GUİDED SERRATUS POSTERİOR SUPERİOR İNTERCOSTAL PLANE BLOCK(SPSIPB) FOR POSTOPERATİVE ANALGESİA FOLLOWİNG BREAST CANCER SURGERY
- Active Comparator: RHOMBOİD İNTERCOSTAL BLOCK(RIB)PATİENTS İN THİS GROUP WİLL RECEİVE AN ULTRASOUND-GUİDED RHOMBOİD İNTERCOSTAL BLOCK(RIB) FOR POSTOPERATİVE ANALGESİA FOLLOWİNG BREAST CANCER SURGERY
Primary Outcome Measure
postoperative pain intensity (VAS score) [ Time Frame: 0, 1, 4, 8, 12, and 24 hours after surgery ]
Central Contacts
- MUSTAFA KILIN, CONSULTANT ANESTHESİOLOGİST+905464569218
Find similar trials
Related Studies
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast CancerRecruiting · Carol Fabian, MD · Kansas City, Kansas
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland